電製藥/生物電醫學市場規模、佔有率和成長分析（按產品類型、設備類型、應用、最終用戶和地區）：產業預測（2025-2032）

2023年，全球電子藥物/生物電藥物市場規模將達到239億美元，從2024年的253.6億美元成長到2032年的407.2億美元。預計將達6.1 %。

由於慢性和急性疾病盛行率上升、人口老化以及主要企業的進步等幾個關鍵因素，生物電子醫學市場預計將顯著成長。一個值得注意的舉措是，2022年1月，生物電子醫學促進會推出“生物電子醫學日”，強調該領域的重要性。結合生物工程、分子醫學和神經病學的電子製藥設備在慢性疾病的治療中變得越來越重要，特別是心血管疾病，這種疾病每年奪走美國超過 61 萬人的生命。對新技術的研發和監管核准的大量投資繼續增加市場潛力，但嚴格的政府法規和潛在的產品召回帶來了挑戰。這些因素的結合導致市場格局迅速發展和擴大。

目錄

介紹

• 分析目的
• 市場範圍
• 定義

分析方法

• 資訊採購
• 次要/主要資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析

主要市場考慮因素

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場魅力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術分析
• 監管分析
• 專利分析
• 案例研究

全球電製藥/生物電醫學市場規模/複合年成長率：依產品分類（2025-2032）

• 市場概況
• 心臟心律調節器/植入式心臟整流去顫器(ICD)
• 人工電子耳
• 脊髓刺激設備
• 深層腦部刺激器
• 迷走神經刺激設備
• 薦骨神經刺激器
• 其他

全球電製藥/生物電醫學市場規模/複合年成長率：按設備類型分類（2025-2032）

• 市場概況
• 植入式裝置
• 非侵入性設備

全球電製藥/生物電醫學市場規模/複合年成長率：按應用分類（2025-2032）

• 市場概況
• 心律不整
• 感覺神經性聽力損失
• 癲癇
• 帕金森氏症
• 其他

全球電製藥/生物電醫學市場規模/複合年成長率：按最終用戶分類（2025-2032）

• 市場概況
• 醫院
• 門診手術中心
• 其他

全球電製藥/生物電醫學市場規模/複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• 美敦力（愛爾蘭）
• 雅培（美國）
• 波士頓科學公司（美國）
• 科利耳有限公司（澳洲）
• LivaNova PLC（英國）
• Biotronik SE & Co. KG（德國）
• electroCore, Inc.（美國）
• 索諾瓦（瑞士）
• Nevro 公司（美國）
• Stimwave LLC（美國）
• SetPoint 醫療（美國）
• 天空醫療科技（英國）
• 卡拉健康（美國）
• NeuroPace, Inc.（美國）
• Koninklijke Philips NV（荷蘭）
• WEINMANN 緊急醫療技術有限公司（德國）
• 索諾瓦控股公司（瑞士）
• 奧迪康醫療 AB（丹麥）
• 生物電子公司（美國）
• MicroTransponder 公司（美國）

結論和建議

Global Electroceuticals Bioelectric Medicine Market size was valued at USD 23.9 billion in 2023 and is poised to grow from USD 25.36 billion in 2024 to USD 40.72 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

The bioelectronic medicine market is poised for significant growth, driven by several key factors, including the rising incidence of chronic and acute diseases, an aging population, and advancements made by leading companies. A notable initiative was the launch of Bioelectronic Medicine Day by the Alliance for Advancing Bioelectronic Medicine in January 2022, highlighting the importance of this field. Electroceutical devices that blend bioengineering, molecular medicine, and neurology are increasingly relevant in treating chronic conditions, particularly cardiovascular diseases, which claim over 610,000 lives annually in the U.S. Significant investments in R&D and regulatory approvals for new technologies continue to enhance market potential, though strict government regulations and potential product recalls pose challenges. The convergence of these factors suggests a rapidly evolving and expanding market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electroceuticals Bioelectric Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electroceuticals Bioelectric Medicine Market Segmental Analysis

Global Electroceuticals Bioelectric Medicine Market is segmented by Product, Device Type, Application, End User and region. Based on Product, the market is segmented into Cardiac Pacemakers and Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators and Others. Based on Device Type, the market is segmented into Implantable Devices and Non-invasive Devices. Based on Application, the market is segmented into Arrhythmia, Sensorineural Hearing Loss, Epilepsy, Parkinson's Disease and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Electroceuticals Bioelectric Medicine Market

The global Electroceuticals Bioelectric Medicine market is primarily driven by the increasing prevalence of neurological and cardiovascular complications among the aging population, which requires innovative medical solutions. As this demographic grows, it fuels the demand for electroceutical devices such as cardiac pacemakers, implantable cardioverter defibrillators, deep brain stimulators, and spinal cord stimulators. Emerging economies, particularly in regions like South Korea, Malaysia, Vietnam, Africa, Israel, Saudi Arabia, and the UAE, present significant growth opportunities for major market players due to their favorable regulatory environments and improving healthcare infrastructures. The expanding patient base and rising healthcare costs further enhance the market's potential, prompting companies to focus on these emerging markets while facing intensified competition in more developed regions.

Restraints in the Global Electroceuticals Bioelectric Medicine Market

The growth of the Global Electroceuticals Bioelectric Medicine market is significantly hampered by the high costs associated with electroceutical devices, such as cochlear implants and neurostimulators, particularly in price-sensitive regions like Asia Pacific, Latin America, and Africa. Many healthcare providers in developing nations, such as Brazil and Mexico, lack the necessary financial resources to invest in advanced technologies. Furthermore, effective deployment of these devices requires extensive training for personnel, adding another layer of difficulty. The need for significant research and development to produce innovative electroceutical products increases manufacturing costs. Additionally, the shortage of skilled professionals, including neurologists and neurosurgeons, further restricts the availability of neurosurgical procedures, negatively impacting market demand for devices like neurostimulators.

Market Trends of the Global Electroceuticals Bioelectric Medicine Market

The Global Electroceuticals Bioelectric Medicine market is witnessing significant growth driven by the increasing acceptance of advanced medical devices such as defibrillators and pacemakers. Technological advancements, exemplified by Abbott Laboratories' FDA-approved Gallant line featuring Bluetooth-integrated implantable cardioverter-defibrillators, are expanding the market's capabilities. The introduction of modern pacemakers equipped with data recording, safe MRI compatibility, and remote monitoring functionalities further stimulates demand. As healthcare providers and patients increasingly recognize the benefits of these innovative therapies, the market is poised for robust expansion, enhancing patient outcomes and driving investments in this burgeoning field of bioelectric medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Electroceuticals Bioelectric Medicine Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cardiac Pacemakers and Implantable Cardioverter Defibrillators
• Cochlear Implants
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Vagus Nerve Stimulators
• Sacral Nerve Stimulators
• Others

Global Electroceuticals Bioelectric Medicine Market Size by Device Type & CAGR (2025-2032)

• Market Overview
• Implantable Devices
• Non-invasive Devices

Global Electroceuticals Bioelectric Medicine Market Size by Application & CAGR (2025-2032)

• Market Overview
• Arrhythmia
• Sensorineural Hearing Loss
• Epilepsy
• Parkinson's Disease
• Others

Global Electroceuticals Bioelectric Medicine Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Global Electroceuticals Bioelectric Medicine Market Size & CAGR (2025-2032)

• North America (Product, Device Type, Application, End User)
  • US
  • Canada
• Europe (Product, Device Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Device Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Device Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Device Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cochlear Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• electroCore, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sonova (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SetPoint Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sky Medical Technology (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cala Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WEINMANN Emergency Medical Technology GmbH + Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sonova Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oticon Medical AB (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioElectronics Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTransponder Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations